AHA 2013 is one the busiest but most exciting times of the year. For this year’s Scientific Sessions, I am very pleased to report that the VAP (Vertical Auto Profile) Lipid Panel is utilized in eight independent investigator-initiated scientific presentations during the conference.
2013 has been a banner year for VAP-involved research projects: starting with the American College of Cardiology in March, continuing with the National Lipid Association Scientific Sessions in May and the eighth annual Cardiometabolic Health Congress (CMHC) in September. VAP is well traveled in 2013 and gaining more attention at every conference.
Most impressive is VAP’s validation of what I see in practice nearly every day — the lipid panel’s ability to support the important clinical utility of testing for comprehensive and accurate cardiovascular risk assessment.